ResearcherUSA Mitchell Cancer InstituteActive in the last 2 years
Santanu Dasgupta
Matched on ORCID iD 0000-0002-1499-0039; OpenAlex author ID A5089555884. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 8
2020: 1 paper · 2021: none · 2022: 1 paper · 2023: none · 2024: 1 paper
Papers 3
- Mitochondrial Translocase TOMM22 Is Overexpressed in Pancreatic Cancer and Promotes Aggressive Growth by Modulating Mitochondrial Protein Import and Function. Last author DOI 10.1158/1541-7786.mcr-23-0138↗
- Detection of mitochondrial DNA mutations in circulating mitochondria-originated extracellular vesicles for potential diagnostic applications in pancreatic aden… Last author DOI 10.1038/s41598-022-22006-5↗
- Comprehensive Analysis of Expression, Clinicopathological Association and Potential Prognostic Significance of RABs in Pancreatic Cancer. Co-author DOI 10.3390/ijms21155580↗
Closest collaborators
The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Seema Singh · 3 shared papers, 2020–2024 · strength 0.53
- Paper Mitochondrial Translocase TOMM22 Is Overexpressed in Pancreatic Cancer and Promotes Aggressive Growth by Modulating Mit… DOI 10.1158/1541-7786.mcr-23-0138↗
- Paper Detection of mitochondrial DNA mutations in circulating mitochondria-originated extracellular vesicles for potential di… DOI 10.1038/s41598-022-22006-5↗
- Paper Comprehensive Analysis of Expression, Clinicopathological Association and Potential Prognostic Significance of RABs in … DOI 10.3390/ijms21155580↗
- Shashi Anand · 3 shared papers, 2020–2024 · strength 0.53
- Paper Mitochondrial Translocase TOMM22 Is Overexpressed in Pancreatic Cancer and Promotes Aggressive Growth by Modulating Mit… DOI 10.1158/1541-7786.mcr-23-0138↗
- Paper Detection of mitochondrial DNA mutations in circulating mitochondria-originated extracellular vesicles for potential di… DOI 10.1038/s41598-022-22006-5↗
- Paper Comprehensive Analysis of Expression, Clinicopathological Association and Potential Prognostic Significance of RABs in … DOI 10.3390/ijms21155580↗
- Mohammad Aslam Khan · 3 shared papers, 2020–2024 · strength 0.53
- Paper Mitochondrial Translocase TOMM22 Is Overexpressed in Pancreatic Cancer and Promotes Aggressive Growth by Modulating Mit… DOI 10.1158/1541-7786.mcr-23-0138↗
- Paper Detection of mitochondrial DNA mutations in circulating mitochondria-originated extracellular vesicles for potential di… DOI 10.1038/s41598-022-22006-5↗
- Paper Comprehensive Analysis of Expression, Clinicopathological Association and Potential Prognostic Significance of RABs in … DOI 10.3390/ijms21155580↗
- Ajay P. Singh · 3 shared papers, 2020–2024 · strength 0.53
- Paper Mitochondrial Translocase TOMM22 Is Overexpressed in Pancreatic Cancer and Promotes Aggressive Growth by Modulating Mit… DOI 10.1158/1541-7786.mcr-23-0138↗
- Paper Detection of mitochondrial DNA mutations in circulating mitochondria-originated extracellular vesicles for potential di… DOI 10.1038/s41598-022-22006-5↗
- Paper Comprehensive Analysis of Expression, Clinicopathological Association and Potential Prognostic Significance of RABs in … DOI 10.3390/ijms21155580↗
- Kunwar Somesh Vikramdeo · 2 shared papers, 2022–2024 · strength 0.39
- Paper Mitochondrial Translocase TOMM22 Is Overexpressed in Pancreatic Cancer and Promotes Aggressive Growth by Modulating Mit… DOI 10.1158/1541-7786.mcr-23-0138↗
- Paper Detection of mitochondrial DNA mutations in circulating mitochondria-originated extracellular vesicles for potential di… DOI 10.1038/s41598-022-22006-5↗
- Moh'd M. Khushman · 2 shared papers, 2020–2022 · strength 0.30
- Paper Detection of mitochondrial DNA mutations in circulating mitochondria-originated extracellular vesicles for potential di… DOI 10.1038/s41598-022-22006-5↗
- Paper Comprehensive Analysis of Expression, Clinicopathological Association and Potential Prognostic Significance of RABs in … DOI 10.3390/ijms21155580↗
- Mary Oluwadamilola Haastrup · 1 shared paper, 2024 · strength 0.23
- Martin J. Heslin · 1 shared paper, 2022 · strength 0.16
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.